Detalles de la búsqueda
1.
Safety and Duration of Effect of 40U PrabotulinumtoxinA-xvfs for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients: A Phase II, Multi-Center, Randomized, Double Blind, Active-Controlled Trial.
Aesthet Surg J
; 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38506148
2.
PrabotulinumtoxinA for Treatment of Millennials With Moderate to Severe Glabellar Lines: Post Hoc Analyses of the Phase III Clinical Study Data.
Dermatol Surg
; 48(6): 664-669, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35616616
3.
PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data.
Aesthet Surg J
; 42(12): 1460-1469, 2022 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35922149
4.
PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color: Post Hoc Analyses of the US Phase III Clinical Study Data.
Dermatol Surg
; 47(4): 516-521, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33165078
5.
The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1409-1422, 2021 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944905
6.
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1423-1438, 2021 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944913
7.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 40(4): 413-429, 2020 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30951166
8.
Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies.
Dermatol Surg
; 45(11): 1381-1393, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30893162
9.
Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1494, 2021 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309676
10.
Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1494-1495, 2021 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34189562
11.
PrabotulinumtoxinA for the treatment of glabellar lines in adults, 65 years of age and older: The fourth in a series of post hoc analyses of the phase III clinical study data.
J Cosmet Dermatol
; 22(6): 1745-1756, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37102990
12.
Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization.
Crit Care Med
; 38(11): 2095-102, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20711070
13.
A lung biopsy tract plug for reduction of postbiopsy pneumothorax and other complications: results of a prospective, multicenter, randomized, controlled clinical study.
J Vasc Interv Radiol
; 21(8): 1235-43.e1-3, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20656223
14.
The safety and effectiveness of the retrievable option inferior vena cava filter: a United States prospective multicenter clinical study.
J Vasc Interv Radiol
; 21(8): 1173-84, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20598570
15.
Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh.
J Vasc Surg
; 45(5): 1029-1037; discussion 1037-8, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17466798
Resultados
1 -
15
de 15
1
Próxima >
>>